<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The synergistic scavenger effects of <z:chebi fb="19" ids="27568">selenium</z:chebi> and <z:chebi fb="9" ids="16796">melatonin</z:chebi> collectively we called Se-Mel was studied on the prevention of neuronal injury induced by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>Male Wistar rats were treated with <z:chebi fb="1" ids="48843">sodium selenite</z:chebi> (0.1 mg/kg, i.p.) and <z:chebi fb="9" ids="16796">melatonin</z:chebi> (10 mg/kg, i.p.) 30 min before the middle carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and immediately after MCAO to male Wistar rats and was continued for 3 days once daily at the interval of 24 h </plain></SENT>
<SENT sid="2" pm="."><plain>Behavioral activity (spontaneous motor activity and motor deficit) was improved in Se-Mel-treated rats as compared to MCAO group rats </plain></SENT>
<SENT sid="3" pm="."><plain>The level of <z:chebi fb="0" ids="16856">glutathione</z:chebi> and the activity of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes was depleted significantly while the content of <z:chebi fb="0" ids="33202">thiobarbituric acid</z:chebi> reactive substances, protein <z:chebi fb="1" ids="23019">carbonyl</z:chebi>, and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> radical (NO(·)) was increased significantly in MCAO group </plain></SENT>
<SENT sid="4" pm="."><plain>Systemic administration of Se-Mel ameliorated <z:mp ids='MP_0003674'>oxidative stress</z:mp> and improves <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion-induced focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Se-Mel also inhibited inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase expression in Se-Mel+MCAO group as compared to MCAO group rats </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, Se-Mel has shown an excellent neuroprotective effect against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury through an anti-ischemic pathway </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, we demonstrated that the pretreatment with Se-Mel at the <z:hpo ids='HP_0003674'>onset</z:hpo> of reperfusion, reduced post-ischemic damage, and improved neurological outcome following transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in male Wistar rat </plain></SENT>
</text></document>